U Power Limited Ordinary Shares (UCAR) had the highest return between April 17, 2023 and April 20, 2023 by a US stock, returning 433.1%.
| ASSET | DATE | % RETURN |
|---|---|---|
U Power Limited Ordinary Shares (UCAR) | 4/17/2023 - 4/20/2023 | 433.09% |
Dermata Therapeutics (DRMA) | 4/17/2023 - 4/20/2023 | 110.29% |
Brand Engagement Network (BNAIW) | 4/17/2023 - 4/20/2023 | 82.98% |
US GoldMining Inc Warrant (USGOW) | 4/17/2023 - 4/20/2023 | 82.42% |
Mobilicom Limited Warrants (MOBBW) | 4/17/2023 - 4/20/2023 | 76.35% |
Edible Garden (EDBLW) | 4/17/2023 - 4/20/2023 | 71% |
Toro (TORO) | 4/17/2023 - 4/20/2023 | 69.33% |
Vyne Therapeutics (VYNE) | 4/17/2023 - 4/20/2023 | 55.98% |
Tenaya Therapeutics (TNYA) | 4/17/2023 - 4/20/2023 | 55.33% |
Matinas BioPharma (MTNB) | 4/17/2023 - 4/20/2023 | 53.8% |
Aethlon Medical (AEMD) | 4/17/2023 - 4/20/2023 | 53.25% |
Super League Enterprise (SLE) | 4/17/2023 - 4/20/2023 | 52.33% |
Bright Minds Biosciences (DRUG) | 4/17/2023 - 4/20/2023 | 52.09% |
Palladyne AI (PDYNW) | 4/17/2023 - 4/20/2023 | 48.51% |
Nexalin Technology (NXLIW) | 4/17/2023 - 4/20/2023 | 46.47% |
Reliance Global (RELI) | 4/17/2023 - 4/20/2023 | 45.82% |
Foxx Development (FOXXW) | 4/17/2023 - 4/20/2023 | 45.19% |
Trevi Therapeutics (TRVI) | 4/17/2023 - 4/20/2023 | 44.68% |
Indaptus Therapeutics (INDP) | 4/17/2023 - 4/20/2023 | 42.23% |
Boqii (BQ) | 4/17/2023 - 4/20/2023 | 41.75% |
error (ZVZZT) | 4/17/2023 - 4/20/2023 | 40.84% |
BitMine Immersion Technologies (BMNR) | 4/17/2023 - 4/20/2023 | 38.89% |
NeuroSense Therapeutics Ltd Warrant (NRSNW) | 4/17/2023 - 4/20/2023 | 38.74% |
Dave Inc Warrants (DAVEW) | 4/17/2023 - 4/20/2023 | 37.37% |
Iveda Solutions Inc Warrant (IVDAW) | 4/17/2023 - 4/20/2023 | 36.85% |
